The CARMA1-Bcl10 Signaling Complex Selectively Regulates JNK2 Kinase in the T Cell Receptor-Signaling Pathway
Open Access
- 1 January 2007
- Vol. 26 (1) , 55-66
- https://doi.org/10.1016/j.immuni.2006.11.008
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivoGenes & Development, 2005
- JNK2: A Negative Regulator of Cellular ProliferationCell Cycle, 2004
- The Molecular Adapter Carma1 Controls Entry of IκB Kinase into the Central Immune SynapseThe Journal of Experimental Medicine, 2004
- Regulation of NF-κB-Dependent Lymphocyte Activation and Development by ParacaspaseScience, 2003
- Regulation of MAP Kinase Signaling Modules by Scaffold Proteins in MammalsAnnual Review of Cell and Developmental Biology, 2003
- Requirement for CARMA1 in Antigen Receptor-Induced NF-κB Activation and Lymphocyte ProliferationCurrent Biology, 2003
- Identifying the MAGUK Protein Carma-1 as a Central Regulator of Humoral Immune Responses and Atopy by Genome-Wide Mouse MutagenesisImmunity, 2003
- MAP Kinases in the Immune ResponseAnnual Review of Immunology, 2002
- Carma1, a CARD‐containing binding partner of Bcl10, induces Bcl10 phosphorylation and NF‐κB activation1FEBS Letters, 2001
- CARD11 and CARD14 Are Novel Caspase Recruitment Domain (CARD)/Membrane-associated Guanylate Kinase (MAGUK) Family Members that Interact with BCL10 and Activate NF-κBJournal of Biological Chemistry, 2001